InnoLAMP™ Microparticle Technology for Sustained CNS Delivery: A Once-Monthly Donepezil Formulation

• Highlighting how long-acting microsphere technology could be applied for CNS indications, with reference to G2GBIO’s pipeline as an example
• Explaining the drug-release mechanism of microspheres in the CNS
• Demonstrating PK profile of monthly injectable Donepezil in animals and humans

Speakers:

Kevin Jung

Vice President, Head of Global Business Division

G2GBIO Inc.